US Patent Issued to Accutar Biotechnology on June 24 for "Aminopyrimidine derivatives as cyclin-dependent kinase inhibitors" (New York, New Jersey, Washington, Connecticut, Indiana Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,248, issued on June 24, was assigned to Accutar Biotechnology Inc. (Cranbury, N.J.).

"Aminopyrimidine derivatives as cyclin-dependent kinase inhibitors" was invented by Xiangzhu Wang (Branford, Conn.), Yimin Qian (Plainsboro, N.J.), Wei He (Zionsville, Ind.), Jie Su (New York), Ke Liu (Bellevue, Wash.) and Jie Fan (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to novel CDK inhibitors, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of diseases and conditions associated with CDK."

The patent was filed on July 22, 2024, under Application No. 18/780,132.

*For fu...